Benefits and Harm of Treatment with P2Y12 Inhibitors beyond 12 Months in Patients with Coronary Artery Disease

Larsen, ML; Grove, EL; Kristensen, SD; Hvas, AM

Hvas, AM (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark.

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2020; 46 (4): 446

Abstract

The trade-off between the benefits and harm of long-term (> 12 months) treatment with P2Y12 inhibitors in patients with coronary artery disease (CA......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索